Barry P Flannelly sold $743K of Incyte (INCY)

Executed Jul 3 2025, disclosed Jul 7 2025, 4 days later.

Value, as filed

$743K

10,903 sh × $68.15

Executed

Jul 3 2025

the trade date, as filed

Disclosed

Jul 7 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Barry P Flannelly EVP & General Manager US profile →

Barry P Flannelly (EVP & General Manager US) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Incyte Corporation (INCY). The largest single filing was $1.3M of INCY (19,147 sh × $67.68, as filed), executed Mar 14 2025.

The name

INCY

Incyte Corporation INCY · Healthcare · 38 filings in 24 months ticker →

Healthcare · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Barry P Flannelly in INCY

INCYSALE Incyte Corporation $1.3M
19,147 sh × $67.68
Exec Mar 14 2025
Filed Mar 18 2025 · 5:30 PM ET INCYSALE Incyte Corporation $293K
3,680 sh across 2 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET